Synopsis: Wockhardt is exiting the US generics market after sustained losses to focus on antibiotics and insulin biologics. This strategic shift aims to drive innovation, profitability, and long-term growth across global markets. During Monday’s trading session,...
The Contract Development and Manufacturing Organization (CDMO) sector involves companies that provide services to help other businesses develop and manufacture pharmaceutical products. They handle tasks like drug development, production, and packaging for various...
The shares of this small cap pharmaceutical stock, involved in the production of finished dosage forms, like injectables and oral drugs hit 10 percent upper circuit on Friday after the company announced its new antibiotic has set a record-breaking success in Phase III...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
